Charles River 14 mai 2026 Charles River Laboratories stock (US1591881009): Q1 earnings beat with updated FY guidance - AD HOC NEWS
IMI 14 mai 2026 IMI plc stock (GB00B1905F76): Reconfirms 2026 guidance after strong Q1 growth - AD HOC NEWS
FierceBiotech 14 mai 2026 BioAge CEO has big plans for 'multi-disease impact' of NLRP3 drug across cardio, ocular and CNS
Merck & Co. 14 mai 2026 AstraZeneca scores with Imfinzi in another bladder cancer trial, rivaling Merck's Keytruda - Fierce Pharma
Merck & Co. 14 mai 2026 Merck & Co., Inc. stock (US58933Y1055): Latest developments and business overview - AD HOC NEWS
Thermo Fisher 14 mai 2026 Nuvation Bio Completes IBTROZI Manufacturing Tech Transfer to Thermo Fisher - Contract Pharma
Eli Lilly 14 mai 2026 Eli Lilly delivers $50M boost to UNICEF’s pediatric health push - Fierce Pharma
FierceBiotech 14 mai 2026 Biopharma leaders rally behind Pazdur for FDA commissioner pick. But does he want the role?